Table 3

Summary of studies concerning IVIG for TEN

Trent

Viard

Prins

Campione

Al-Mutairi

Shortt

Tan

Stella

Rajaratnam

Bachot

Brown

Schneck

2003

1998

2003

2003

2004

2004

2005

2007

2010

2003

2004

2008

(80)

(44)

(73)

(76)

(74)

(78)

(79)

(82)

(81)

(72)

(75)

(69)


Study design

Retro

Prosp

Retro

Prosp

Prosp

Retro

Retro

Retro

Retro

Prosp

Retro

Retro

N/

N/

N/

N/

N/

N/

N/

Cont

N/

N/

N/

Cont

Cont

Cont

Cont

Cont

Cont

Cont

Cont

Cont

Cont

Cont


Patients

24

10

48

10

12

16

12

23

14

34

24

75


Detachm.(%)

44

39

45

49

58

"65"

---

---

"44"

19

49

---


Total dose IVIG (g/kg)

4

3

3

2

2-5

2.8

2

---

3.3

2

1.6

1.9 (0.7-2.3)


Predicted mortality (SCORTEN/APACHE*) in %

33

---

---

35

---

38 *

---

35.8

36

24

28.6

25


Actual mortality in %

4

0

12

10

0

25

8

26

21

32

41.7

34


Harr and French Orphanet Journal of Rare Diseases 2010 5:39   doi:10.1186/1750-1172-5-39

Open Data